PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsAmphastar Pharmaceuticals
Amphastar Pharmaceuticals(AMPH)
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AmphadaseHyaluronidase2004-10-26
CortrosynCosyntropin1982-01-01
—
DuocaineBupivacaine, Lidocaine2003-05-232025-2041
EnoxaparinEnoxaparin2011-09-19
GanirelixGanirelix2022-04-07
GlucagonGlucagon2020-12-282036-2039
IsoproterenolIsoproterenol2018-06-18
Ketorolac tromethamineKetorolac tromethamine2004-07-21
—
MedroxyprogesteroneMedroxyprogesterone2017-11-28
Neostigmine methylsulfateNeostigmine methylsulfate2017-09-252038
NitroprussideNitroprusside2017-12-18
—
SuccinylcholineSuccinylcholine2020-06-08
—
VasopressinVasopressin2022-07-182035
—
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Hyaluronidase
Cycloplegics
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use